ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for NGNE

Stock NameNeurogene Inc
TickerNGNE(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate NGNE holdings

News associated with NGNE

Mitsubishi UFJ Asset Management Co. Ltd. Buys 941 Shares of Neurogene Inc. (NASDAQ:NGNE)
Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Neurogene Inc. (NASDAQ:NGNE – Free Report) by 9.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,231 shares of the company’s stock after purchasing an additional 941 shares during the quarter. Mitsubishi UFJ Asset […] - 2025-08-15 04:46:52
Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have earned an average rating of “Moderate Buy” from the eight research firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month […] - 2025-07-03 04:38:54
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Moderate Buy” from Analysts
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has received an average rating of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among […] - 2025-06-13 02:55:10
Neurogene Inc. (NASDAQ:NGNE) Shares Sold by BNP Paribas Financial Markets
BNP Paribas Financial Markets trimmed its stake in Neurogene Inc. (NASDAQ:NGNE – Free Report) by 36.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,380 shares of the company’s stock after selling 790 shares during the quarter. BNP Paribas Financial Markets’ holdings in Neurogene […] - 2025-06-05 04:18:55
Neurogene (NASDAQ:NGNE) Stock Rating Lowered by Robert W. Baird
Robert W. Baird cut shares of Neurogene (NASDAQ:NGNE – Free Report) from an outperform rating to a neutral rating in a research note released on Friday, Marketbeat.com reports. They currently have $24.00 price target on the stock, down from their previous price target of $38.00. A number of other research analysts have also recently weighed […] - 2025-05-19 04:34:54
Baird R W Downgrades Neurogene (NASDAQ:NGNE) to Hold
Baird R W downgraded shares of Neurogene (NASDAQ:NGNE – Free Report) from a strong-buy rating to a hold rating in a research report sent to investors on Friday,Zacks.com reports. NGNE has been the topic of a number of other reports. William Blair restated an “outperform” rating on shares of Neurogene in a research report on […] - 2025-05-19 02:24:54
Schonfeld Strategic Advisors LLC Reduces Stake in Neurogene Inc. (NASDAQ:NGNE)
Schonfeld Strategic Advisors LLC reduced its holdings in Neurogene Inc. (NASDAQ:NGNE – Free Report) by 71.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,189 shares of the company’s stock after selling 23,477 shares during the quarter. Schonfeld Strategic Advisors LLC’s holdings in […] - 2025-05-14 04:49:02
Neurogene Inc. (NASDAQ:NGNE) Receives Average Rating of “Buy” from Analysts
Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […] - 2025-04-24 02:44:52
BMO Capital Markets Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock Price
Neurogene (NASDAQ:NGNE – Get Free Report) had its target price lowered by equities researchers at BMO Capital Markets from $45.00 to $16.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price would suggest a potential upside of 40.85% from the […] - 2025-04-16 02:56:51
Mitsubishi UFJ Asset Management Co. Ltd. Raises Holdings in Neurogene Inc. (NASDAQ:NGNE)
Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Neurogene Inc. (NASDAQ:NGNE – Free Report) by 72.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,290 shares of the company’s stock after acquiring an additional 4,334 shares […] - 2025-04-04 05:12:55
Neurogene Inc. (NASDAQ:NGNE) Receives $59.80 Consensus PT from Brokerages
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are presently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among […] - 2025-03-28 03:48:44
HC Wainwright Lowers Neurogene (NASDAQ:NGNE) Price Target to $50.00
Neurogene (NASDAQ:NGNE – Get Free Report) had its target price lowered by analysts at HC Wainwright from $55.00 to $50.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 209.79% from the company’s current price. Neurogene Price […] - 2025-03-27 04:32:49
Neurogene (NASDAQ:NGNE) Given Outperform Rating at William Blair
William Blair restated their outperform rating on shares of Neurogene (NASDAQ:NGNE – Free Report) in a report published on Tuesday morning,RTT News reports. Separately, HC Wainwright reduced their price target on Neurogene from $55.00 to $50.00 and set a “buy” rating for the company in a report on Tuesday. Seven equities research analysts have rated […] - 2025-03-26 04:38:43
3,150 Shares in Neurogene Inc. (NASDAQ:NGNE) Purchased by China Universal Asset Management Co. Ltd.
China Universal Asset Management Co. Ltd. bought a new position in shares of Neurogene Inc. (NASDAQ:NGNE – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 3,150 shares of the company’s stock, valued at approximately $72,000. Several other institutional […] - 2025-02-04 06:53:04
Neurogene Inc. (NASDAQ:NGNE) Receives $60.83 Average Price Target from Brokerages
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has been assigned a consensus rating of “Buy” from the eight research firms that are currently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month target […] - 2025-02-03 04:24:57

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) NGNE holdings

DateNumber of NGNE Shares HeldBase Market Value of NGNE SharesLocal Market Value of NGNE SharesChange in NGNE Shares HeldChange in NGNE Base ValueCurrent Price per NGNE Share HeldPrevious Price per NGNE Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NGNE by Blackrock for IE00BYXG2H39

Show aggregate share trades of NGNE

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY7223.09024.300 24.179USD 1,741 17.72
2025-10-03BUY16822.34024.500 24.284USD 4,080 17.69
2025-10-02BUY2420.98021.412 21.369USD 513 17.67
2025-09-30BUY4817.33018.060 17.987USD 863 17.67
2025-09-26BUY4817.82018.130 18.099USD 869 17.67
2025-09-25BUY4817.40517.450 17.446USD 837 17.68
2025-09-18BUY2418.68018.940 18.914USD 454 17.67
2025-09-17BUY7217.71018.395 18.327USD 1,320 17.67
2025-09-11SELL-2420.08020.720 20.656USD -496 17.65 Loss of -72 on sale
2025-09-10BUY4818.60019.630 19.527USD 937 17.65
2025-09-05SELL-2419.95020.665 20.594USD -494 17.61 Loss of -72 on sale
2025-08-29SELL-7218.48019.005 18.952USD -1,365 17.58 Loss of -99 on sale
2025-08-27BUY4819.69520.360 20.294USD 974 17.56
2025-08-26SELL-2420.02020.460 20.416USD -490 17.54 Loss of -69 on sale
2025-08-25BUY2419.98020.155 20.138USD 483 17.53
2025-08-20SELL-9619.61019.900 19.871USD -1,908 17.50 Loss of -228 on sale
2025-08-18BUY4820.45021.500 21.395USD 1,027 17.47
2025-08-08SELL-4821.22022.250 22.147USD -1,063 17.37 Loss of -229 on sale
2025-08-05BUY2321.45021.810 21.774USD 501 17.29
2025-08-01SELL-6921.78022.755 22.657USD -1,563 17.23 Loss of -375 on sale
2025-07-30BUY9221.87023.800 23.607USD 2,172 17.16
2025-07-17SELL-4622.60023.270 23.203USD -1,067 16.83 Loss of -293 on sale
2025-07-11SELL-19221.43022.200 22.123USD -4,248 16.67 Loss of -1,047 on sale
2025-07-07BUY7219.50020.550 20.445USD 1,472 16.54
2025-07-02BUY1,32019.75021.190 21.046USD 27,781 16.46
2025-06-25BUY4816.88017.445 17.388USD 835 16.47
2025-06-11BUY4820.92022.000 21.892USD 1,051 16.26
2025-06-10BUY4821.58021.730 21.715USD 1,042 16.22
2025-06-04SELL-2421.67023.140 22.993USD -552 16.01 Loss of -168 on sale
2025-04-23BUY2415.44017.000 16.844USD 404 15.81
2025-04-10SELL-1928.9709.300 9.267USD -1,779 16.42 Profit of 1,373 on sale
2025-04-08SELL-247.3408.398 8.292USD -199 16.68 Profit of 201 on sale
2025-04-07SELL-247.8658.800 8.707USD -209 16.82 Profit of 195 on sale
2025-04-04SELL-1208.7909.596 9.515USD -1,142 16.95 Profit of 892 on sale
2025-04-01BUY969.65511.985 11.752USD 1,128 17.18
2025-03-31SELL-7211.71013.830 13.618USD -980 17.27 Profit of 263 on sale
2025-03-14SELL-38416.70017.240 17.186USD -6,599 17.72 Profit of 204 on sale
2025-03-07SELL-4817.28017.480 17.460USD -838 17.76 Profit of 15 on sale
2025-03-04SELL-2416.35016.510 16.494USD -396 17.84 Profit of 32 on sale
2025-02-25BUY4816.76016.930 16.913USD 812 17.97
2025-02-19SELL-2416.97017.800 17.717USD -425 18.08 Profit of 9 on sale
2025-02-13BUY7218.77019.480 19.409USD 1,397 18.06
2025-02-12BUY2418.57018.610 18.606USD 447 18.04
2025-02-11BUY9617.79018.900 18.789USD 1,804 18.05
2025-01-17BUY9616.60017.746 17.631USD 1,693 19.79
2025-01-16BUY9617.63018.480 18.395USD 1,766 20.10
2025-01-10SELL-4819.58020.850 20.723USD -995 21.96 Profit of 59 on sale
2025-01-08SELL-9621.49022.230 22.156USD -2,127 22.89 Profit of 70 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NGNE

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1953,735073,87772.7%
2025-09-1832,819072,46645.3%
2025-09-1717,19320754,89731.3%
2025-09-1639,8440110,85635.9%
2025-09-1515,130040,36937.5%
2025-09-1225,758063,09840.8%
2025-09-1135,2800678,6805.2%
2025-09-1026,962034,72177.7%
2025-09-0911,112017,44663.7%
2025-09-0817,364035,85148.4%
2025-09-0525,986099,70526.1%
2025-09-0419,3451,90027,61770.0%
2025-09-0323,625034,28568.9%
2025-09-0210,864019,71255.1%
2025-08-2920,341051,99839.1%
2025-08-2813,467044,81130.1%
2025-08-2714,038037,89837.0%
2025-08-2611,064043,89825.2%
2025-08-2521,351035,03660.9%
2025-08-2213,787061,63122.4%
2025-08-2110,767016,68264.5%
2025-08-2015,5661518,52684.0%
2025-08-1925,7088135,87071.7%
2025-08-1833,8019378,19543.2%
2025-08-1536,032064,27356.1%
2025-08-1443,923064,33268.3%
2025-08-1331,03227165,26447.5%
2025-08-1235,241045,61277.3%
2025-08-1145,933055,76582.4%
2025-08-0821,633027,67278.2%
2025-08-0731,116033,40793.1%
2025-08-0631,215040,11377.8%
2025-08-0564,951074,52487.2%
2025-08-0412,550019,02066.0%
2025-08-0141,9502649,96484.0%
2025-07-3116,761019,79184.7%
2025-07-3052,8647092,41357.2%
2025-07-2945,98340064,23371.6%
2025-07-2824,175034,01471.1%
2025-07-2517,132023,52372.8%
2025-07-2433,467041,38480.9%
2025-07-2343,889076,28857.5%
2025-07-2236,561048,19075.9%
2025-07-2131,2088956,34855.4%
2025-07-1831,073042,83572.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy